[HTML] sciencedirect.com

[HTML][HTML] Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: a retrospective cohort study using three healthcare …

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava, L Li - Vaccine, 2022 - Elsevier
Background Yellow fever (YF) vaccines are highly effective and have a well-established
safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated …
被引用次数：5 相关文章

Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava… - Vaccine, 2022 - pubmed.ncbi.nlm.nih.gov
Background Yellow fever (YF) vaccines are highly effective and have a well-established
safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated …

Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: a retrospective cohort study using three healthcare databases.

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava, L Li - 2022 - cabidigitallibrary.org
Background: Yellow fever (YF) vaccines are highly effective and have a well-established
safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated …

Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava, L Li - Vaccine, 2022 - europepmc.org
Background Yellow fever (YF) vaccines are highly effective and have a well-established
safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated …

[引用][C] Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava, L Li - 2022